Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

L
Löbmann, Korbinian

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Korbinian Löbmann
Favorite
LaBella, Gus

Mikart
(T1330-10-59) High Shear Wet Granulation Scale-Up Using Basic Principles
Gus LaBella
Favorite
Lachman, Marek

Biogrund GmbH
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Marek Lachman
Favorite
Lacin, Nursima

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Nursima Lacin
Favorite
Lackey, Alan

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Alan Lackey
Favorite
Lacombe, Justin

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Justin Lacombe
Favorite
Ladi, Rukmini

Butler University
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Rukmini Ladi
Favorite
Lahaie, Mathieu

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Mathieu Lahaie
Favorite
Lai, Ju-Ping

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Ju-Ping Lai
Favorite
Laing, Catherine

Fortrea Clinical Research Unit Ltd
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Catherine Laing
Favorite
Lai, Weidong George

Alltrna, Inc.
(M1530-02-08) PK/PD Modeling for Liver Targeting LNP Formulated tRNA in Transgenic Mice Containing a Premature Termination Codon on the Human Methylmalonyl-CoA Mutase (hMMut)
Weidong George Lai
Favorite
Lai, Yuen Sze

Chinese University of Hong Kong, The
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Yuen Sze Lai
Favorite
Lai, Yurong

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Yurong Lai
Favorite
Lakatosh, Eric

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Eric Lakatosh
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Eric Lakatosh
Favorite
Lakkakula, Harini

Novi High School
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Harini Lakkakula
Favorite
Lakkala, Preethi

University of Mississippi
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Preethi Lakkala
Favorite
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Preethi Lakkala
Favorite
Lakshmi, Divya

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Divya Lakshmi
Favorite
Laliwala, Aayushi

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Aayushi Laliwala
Favorite
Lal, Manjari

PATH
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Manjari Lal
Favorite
Lamm, Matthew

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Matthew Lamm
Favorite
Lamprecht, Alf

University of Bonn
(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles
Alf Lamprecht
Favorite
(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin
Alf Lamprecht
Favorite
(W1030-11-63) Crystalline Craftsmanship: Controlling Surface Roughness of Spray-Freeze-Dried Particles
Alf Lamprecht
Favorite
(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder
Alf Lamprecht
Favorite
Lamptey, Richard

Palm Beach Atlantic University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Richard Lamptey
Favorite
Lam, Stephanie

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Stephanie Lam
Favorite
Landry, France

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
France Landry
Favorite
Lan, Jing

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Jing Lan
Favorite
Lao, Yeh-Hsing

University at Buffalo
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Yeh-Hsing Lao
Favorite
Laptieva, Oksana

Physiolution GmbH
(M1530-03-15) Biopredictive Dissolution of Budesonide Enteric Pellets under Simulated Fasted Intake Conditions
Oksana Laptieva
Favorite
Larmon, Ryan

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Ryan Larmon
Favorite
Larraneta, Eneko

Queen's University Belfast
(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants
Eneko Larraneta
Favorite
Lassman, Michael

Merck & Co., Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Michael Lassman
Favorite
Lautner, Gergely

University of Michigan
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Gergely Lautner
Favorite
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Gergely Lautner
Favorite
Lavasanifar, Afsaneh

University of Alberta
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Afsaneh Lavasanifar
Favorite
Lavertu, Marc

Polytechnique Montréal
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Marc Lavertu
Favorite
Lawal, Kamaru

Ashland Specialty Ingredients
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Kamaru Lawal
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Kamaru Lawal
Favorite
Lawal, Temitope

University of Ibadan
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Temitope Lawal
Favorite
Law, Devalina

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Devalina Law
Favorite
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Devalina Law
Favorite
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Devalina Law
Favorite
Laws, Amy

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Amy Laws
Favorite
Layek, Buddhadev

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Buddhadev Layek
Favorite
(T1330-01-06) A Novel Liposome Delivering Adavosertib for Ovarian Cancer Treatment
Buddhadev Layek
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Buddhadev Layek
Favorite
Layton, Catharine E.

Waters Corporation
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Catharine E. Layton
Favorite
Lazarte, Jassy Mary

Florida A&M University
(M0930-04-19) Genetically Engineered PD-L1 Targeted Exosomes for Immunotherapy of Doxorubicin Resistant Triple Negative Breast Cancers
Jassy Mary Lazarte
Favorite
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Jassy Mary Lazarte
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Jassy Mary Lazarte
Favorite
Lazeration, Madison

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Madison Lazeration
Favorite
Le Merdy, Maxime

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Maxime Le Merdy
Favorite
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Maxime Le Merdy
Favorite
Lechanteur, Anna

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Anna Lechanteur
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Anna Lechanteur
Favorite
Lee, Beom-Jin

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Beom-Jin Lee
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Beom-Jin Lee
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Beom-Jin Lee
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Beom-Jin Lee
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Beom-Jin Lee
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Beom-Jin Lee
Favorite
Lee, Christine

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Christine Lee
Favorite
Lee, Chunggeon

Korea Institue of Toxicology
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Chunggeon Lee
Favorite
Lee, Cylivia

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Cylivia Lee
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Cylivia Lee
Favorite
Lee, Devin

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Devin Lee
Favorite
Lee, Dong Yun

Hanyang University
(M1030-03-14) Enhancing Glycyrrhizin Delivery to White Adipose Tissue: A Promising Approach for Safe and Effective Obesity Treatment
Dong Yun Lee
Favorite
(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation
Dong Yun Lee
Favorite
Lee, Ernest

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Ernest Lee
Favorite
Lee, Eun Hee

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Eun Hee Lee
Favorite
Lee, Gong Yeal

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Gong Yeal Lee
Favorite
Lee, Hyo Jung

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Hyo Jung Lee
Favorite
Lee, Jangik

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jangik Lee
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jangik Lee
Favorite
Lee, Jennifer

US Food and Drug Administration
(M1330-02-08) In Vitro Assays for the Evaluation of Innate Immunogenicity in Generic Peptide Drug Products
Jennifer Lee
Favorite
Lee, Jongchan

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Jongchan Lee
Favorite
Lee, Jong-Ju

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Jong-Ju Lee
Favorite
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Jong-Ju Lee
Favorite
Lee, Juseung

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Juseung Lee
Favorite
Lee, Sang Min

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Sang Min Lee
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Sang Min Lee
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Sang Min Lee
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Sang Min Lee
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Sang Min Lee
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Sang Min Lee
Favorite
Lee, Sanghwa

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Sanghwa Lee
Favorite
Lee, Steve

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Steve Lee
Favorite
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Steve Lee
Favorite
Lee, Tae Suk

Sungkyunkwan University
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Tae Suk Lee
Favorite
Lee, Yerin

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Yerin Lee
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Yerin Lee
Favorite
Lefancheck, Jenna

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Jenna Lefancheck
Favorite
Leff, Isaac

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Isaac Leff
Favorite
Lehocky, Robert

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Robert Lehocky
Favorite
Leightner, Andrew

Waters Corp
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Andrew Leightner
Favorite
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Andrew Leightner
Favorite
Leipold, Douglas

Genentech, Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Douglas Leipold
Favorite
Leite-Silva, Vânia

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Vânia Leite-Silva
Favorite
Lei, Yuchen

University of Michigan
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Yuchen Lei
Favorite
Leo, M. Dennis

University of Tennessee Health Sciences Center
(M1530-06-31) Insulin Resistance Triggers Histamine Release from Endothelial Cells Which Disrupts Endothelial Barrier Function and Causes Vasoconstriction
M. Dennis Leo
Favorite
Leone, Anthony

Bristol-Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Anthony Leone
Favorite
LeSaint, Johnathan

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Johnathan LeSaint
Favorite
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Johnathan LeSaint
Favorite
Le, Sunny

BioPharma Services Inc.
(M0930-02-12) Sex, Racial, and Ethnic Representation in COVID-19 Vaccine Clinical Trials Conducted in US - A Systematic Review Compared to 2020 US Census Data
Sunny Le
Favorite
Leung, Sharon Shui Yee

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Sharon Shui Yee Leung
Favorite
(M1230-01-05) Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants
Sharon Shui Yee Leung
Favorite
Leung, Zeno

Jean-Marie Pharmacal Co., Ltd.
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Zeno Leung
Favorite
Lewis, Julie

Harvard Medical School
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Julie Lewis
Favorite
Lewis, Mae

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Mae Lewis
Favorite
Li, Airong

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Airong Li
Favorite
Liang, Hong

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Hong Liang
Favorite
Liang, Huan

Pharmascience, Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Huan Liang
Favorite
Liang, Peipei

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Peipei Liang
Favorite
Liang, Wentao

Wake Forest University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Wentao Liang
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Wentao Liang
Favorite
Liang, Wenzhong

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Wenzhong Liang
Favorite
Liang, Xiaomin

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Xiaomin Liang
Favorite
Liang, Xu

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Xu Liang
Favorite
Liao, Lili

Frontage Laboratories, Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Lili Liao
Favorite
Liao, Xiaolu

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Xiaolu Liao
Favorite
Li, Chenglong

University of Florida
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Chenglong Li
Favorite
Liebler, Daniel

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Daniel Liebler
Favorite
Li, Fangfang

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Fangfang Li
Favorite
Li, Gloria

Bristol-Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Gloria Li
Favorite
Li, Ho Yuet

ZSHK Laboratories Ltd.
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Ho Yuet Li
Favorite
Li, Huanhuan

Queen's University Belfast
(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide
Huanhuan Li
Favorite
(W0930-02-07) Revolutionising Microneedle-Based Transdermal Delivery: A Colourful Approach to Efficiency Feedback and User Navigation
Huanhuan Li
Favorite
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Huanhuan Li
Favorite
Li, Jessica

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Jessica Li
Favorite
Li, Ji

University of Michigan
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Ji Li
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Ji Li
Favorite
Li, Jiahao

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Jiahao Li
Favorite
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Jiahao Li
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Jiahao Li
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Jiahao Li
Favorite
Li, Jiahui

University of Utah
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Jiahui Li
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Jiahui Li
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Jiahui Li
Favorite
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jiahui Li
Favorite
Li, Jinghan

University of Minnesota
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Jinghan Li
Favorite
Li, Jingzhe

Boehringer Ingelheim Pharmaceuticals, Inc.
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Jingzhe Li
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Jingzhe Li
Favorite
Li, Keith

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Keith Li
Favorite
Li, Lan

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Lan Li
Favorite
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Lan Li
Favorite
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Lan Li
Favorite
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Lan Li
Favorite
Li, Lu

University of Buffalo
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Lu Li
Favorite
Li, Mengyue

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Mengyue Li
Favorite
Lim, Hye Lim

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Hye Lim Lim
Favorite
Li, Ming

ZSHK Laboratories Ltd.
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Ming Li
Favorite
Li, Ming

Alexion Pharmaceuticals, Inc.
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Ming Li
Favorite
Lim, Tyler

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Tyler Lim
Favorite
Lim, Yun-Seo

Chungju Weedahm Integrative Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Yun-Seo Lim
Favorite
Li, Na

University of Connecticut
(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
Na Li
Favorite
Lingappa, Vishwanath R.

Prosetta Biosciences, Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Vishwanath R. Lingappa
Favorite
Ling, Jing

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Jing Ling
Favorite
Lin, Jennifer

St. John's School
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Jennifer Lin
Favorite
Lin, John

Frontage Laboratories, Inc.
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
John Lin
Favorite
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
John Lin
Favorite
Lino, Paulo

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Paulo Lino
Favorite
Lin, Sarah

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Sarah Lin
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Sarah Lin
Favorite
Lin, Shin-Yan

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Shin-Yan Lin
Favorite
Lin, Xinhao

University of Connecticut
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Xinhao Lin
Favorite
Lin, Yi Yu

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Yi Yu Lin
Favorite
Lin, Zhe-Ju

Andros Pharmaceuticals Co., Ltd.
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Zhe-Ju Lin
Favorite
Lin, Zhixing

New Jersey Institute of Technology
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Zhixing Lin
Favorite
Lin, Zhoumeng

University of Florida
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Zhoumeng Lin
Favorite
Li, Ping

Washington University School of Medicine in Saint Louis
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Ping Li
Favorite
Li, Ran

Genentech Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Ran Li
Favorite
Li, Shannuo

University of Utah, College of Pharmacy
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Shannuo Li
Favorite
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Shannuo Li
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Shannuo Li
Favorite
Li, Shawn

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Shawn Li
Favorite
Li, Shengni

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Shengni Li
Favorite
Li, Shu

Queen's University Belfast
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Shu Li
Favorite
Li, Tao

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Tao Li
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Tao Li
Favorite
Little, Steven

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Steven Little
Favorite
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Steven Little
Favorite
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Steven Little
Favorite
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Steven Little
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Steven Little
Favorite
Littrel, Chad A.

University of Florida
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Chad A. Littrel
Favorite
Liu, Aihua

Resolian
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
Aihua Liu
Favorite
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Aihua Liu
Favorite
Liu, Anita Ping-wen

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Anita Ping-wen Liu
Favorite
Liu, David

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
David Liu
Favorite
Liu, Fang

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Fang Liu
Favorite
Liu, Hanghui

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Hanghui Liu
Favorite
Liu, Jia-Jhen

Andros Pharmaceuticals Co., Ltd.
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Jia-Jhen Liu
Favorite
Liu, Jixin

Croda Inc.
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Jixin Liu
Favorite
Liu, Joseph

University of Texas at Austin
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Joseph Liu
Favorite
Liu, Mingtao

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Mingtao Liu
Favorite
Liu, Peng

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Peng Liu
Favorite
Liu, Qing

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Qing Liu
Favorite
Liu, Stephanie

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Stephanie Liu
Favorite
Liu, Tongzhou

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Tongzhou Liu
Favorite
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Tongzhou Liu
Favorite
Liu, Tony

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Tony Liu
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Tony Liu
Favorite
Liu, Yang

United States Pharmacopeia
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Yang Liu
Favorite
Liu, Zhanjie (Jason)

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Zhanjie (Jason) Liu
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Zhanjie (Jason) Liu
Favorite
Liu, Zhiwei

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Zhiwei Liu
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Zhiwei Liu
Favorite
Li, Xiaoling

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Xiaoling Li
Favorite
Li, Xiaotong

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Xiaotong Li
Favorite
Li, XinMing

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
XinMing Li
Favorite
Li, Xun

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Xun Li
Favorite
Li, Xuni

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Xuni Li
Favorite
Li, Yan

FAMU-FSU College of Engineering
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Yan Li
Favorite
Li, Yan

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Yan Li
Favorite
Li, Yan

FAMU-FSU College of Engineering
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Yan Li
Favorite
Liyanage, Ishanka

US Food and Drug Administration
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Ishanka Liyanage
Favorite
Li, Yang

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Yang Li
Favorite
Li, Yaocun

Queen's University Belfast
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Yaocun Li
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Yaocun Li
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Yaocun Li
Favorite
Li, Yi

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Yi Li
Favorite
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Yi Li
Favorite
Li, Yongzhe

Purdue University
(T1530-06-36) DoE-Based Optimization of RNA Nanosac Lyophilization for Cold-Chain-Free Storage and Transportation
Yongzhe Li
Favorite
Li, Yuan

Biotage LLC
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Yuan Li
Favorite
Li, Yunsong

Wuxi Biologics
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Yunsong Li
Favorite
Li, Zhiyu

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Zhiyu Li
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Zhiyu Li
Favorite
Lobo, Shabbir

Bayer Consumer Care
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Shabbir Lobo
Favorite
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Shabbir Lobo
Favorite
(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Shabbir Lobo
Favorite
(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Shabbir Lobo
Favorite
Lo, Chi-Sheng

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Chi-Sheng Lo
Favorite
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Chi-Sheng Lo
Favorite
Lockwood, Chris

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Chris Lockwood
Favorite
Lo, Dakshesh

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Dakshesh Lo
Favorite
Loebenberg, Raimar

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Raimar Loebenberg
Favorite
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Raimar Loebenberg
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Raimar Loebenberg
Favorite
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Raimar Loebenberg
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Raimar Loebenberg
Favorite
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Raimar Loebenberg
Favorite
(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products
Raimar Loebenberg
Favorite
(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification
Raimar Loebenberg
Favorite
Loew, Nadine

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Nadine Loew
Favorite
Loftin, Charles

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Charles Loftin
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Charles Loftin
Favorite
Lokesh, Rakshitha

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Rakshitha Lokesh
Favorite
Long, Bonnie

University of Utah
(M1430-01-01) Engineering Novel Antibody-Drug Conjugates with Dual Payloads to Improve the Incidence of Drug Resistance Associated with the Use of Antibody-Drug Conjugates in Oncology
Bonnie Long
Favorite
Longest, Worth

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Worth Longest
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Worth Longest
Favorite
Look, Jennifer

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Jennifer Look
Favorite
Losehand, Udo

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Udo Losehand
Favorite
Los, Nina

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Nina Los
Favorite
Lou, Hao

University of Kansas
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Hao Lou
Favorite
Lou, Yang

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Yang Lou
Favorite
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Yang Lou
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Yang Lou
Favorite
Lowe, Val

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Val Lowe
Favorite
Lozeau, Lindsay

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Lindsay Lozeau
Favorite
Lozoya, Maria

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Maria Lozoya
Favorite
Luca, Lien

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Lien Luca
Favorite
Lu, Haiyan

US Food and Drug Administration
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Haiyan Lu
Favorite
Lu, Ida

St. John's University
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Ida Lu
Favorite
Lukacova, Viera

Simulations Plus, Inc.
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Viera Lukacova
Favorite
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Viera Lukacova
Favorite
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Viera Lukacova
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Viera Lukacova
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Viera Lukacova
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Viera Lukacova
Favorite
Luke, Markham

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Markham Luke
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Markham Luke
Favorite
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Markham Luke
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Markham Luke
Favorite
Lulla, Mukesh

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Mukesh Lulla
Favorite
Lumay, Geoffroy

University of Liege
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Geoffroy Lumay
Favorite
Luna, Stephanie

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Stephanie Luna
Favorite
Lund, Thomas

Catalent, Inc.
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Thomas Lund
Favorite
Lu, Niannian

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Niannian Lu
Favorite
Luo, Linjie

Shenzhen University
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Linjie Luo
Favorite
Luo, Yangchao

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Yangchao Luo
Favorite
Lupo, Marco

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Marco Lupo
Favorite
Lu, Tian-Sheng

Medpace Bioanalytical Labs
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Tian-Sheng Lu
Favorite
Luxbacher, Thomas

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Thomas Luxbacher
Favorite
Lu, Xiaofeng

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Xiaofeng Lu
Favorite
Lu, Xiuling

University of Connecticut
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Xiuling Lu
Favorite
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Xiuling Lu
Favorite
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Xiuling Lu
Favorite
Lu, Yang

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Yang Lu
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Yang Lu
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Yang Lu
Favorite
Lu, Yifan

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Yifan Lu
Favorite
Lu, Yizhou

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Yizhou Lu
Favorite
Lynch, Patrick

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Patrick Lynch
Favorite